Package 76420-051-20

{"route": ["ORAL"], "spl_id": "b21449e8-c203-520d-e053-2995a90ad298", "openfda": {"nui": ["N0000175935", "M0028311", "N0000182141", "N0000190114", "N0000185503"], "unii": ["H1250JIK0A"], "rxcui": ["197517"], "spl_set_id": ["a12e4d38-e0f8-4467-a26c-bb25a342aa92"], "pharm_class_cs": ["Macrolides [CS]"], "pharm_class_epc": ["Macrolide Antimicrobial [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "manufacturer_name": ["Asclemed USA, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "14 TABLET in 1 BOTTLE (76420-051-14)", "package_ndc": "76420-051-14", "marketing_start_date": "20201020"}, {"sample": false, "description": "20 TABLET in 1 BOTTLE (76420-051-20)", "package_ndc": "76420-051-20", "marketing_start_date": "20201020"}], "brand_name": "Clarithromycin", "product_id": "76420-051_b21449e8-c203-520d-e053-2995a90ad298", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Macrolide Antimicrobial [EPC]", "Macrolides [CS]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "76420-051", "generic_name": "Clarithromycin", "labeler_name": "Asclemed USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Clarithromycin", "active_ingredients": [{"name": "CLARITHROMYCIN", "strength": "500 mg/1"}], "application_number": "ANDA065136", "marketing_category": "ANDA", "marketing_start_date": "20050825", "listing_expiration_date": "20261231"}